Article
Genetically engineered bacteria as inflammatory bowel disease therapeutics
31 Aug 2024
Abstract excerpt
Inflammatory bowel disease (IBD) is a chronic and recurrent disease caused by immune response disorders that disrupt the intestinal lumen symbiotic ecosystem and dysregulate mucosal immune functions. Current therapies available for IBD primarily focus on symptom management, making early diagnosis and prompt intervention challenging. The development of genetically engineered bacteria using synthetic biology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
